Viking Therapeutics (VKTX) Payables (2014 - 2026)
Viking Therapeutics' Payables was $69.01 million in Q2 2026, compared with $5.49 million a year earlier and up 2.7% from the prior quarter.
Powered by 
Analysis
Viking Therapeutics (VKTX) Payables (2014 - 2026) Analysis & Trends
At the end of FY2025, Payables at Viking Therapeutics came in at $53.25 million, up 442.7% from FY2024.
- Payables shows a five-year compound annual growth rate of 67.9% (FY2020 to FY2025).
- In earlier years, Payables was $9.81 million in FY2024 (+30.6%), $7.51 million in FY2023 (-11.9%), $8.53 million in FY2022 (+490.7%) and $1.44 million in FY2021 (-63.8%).
- The Q2 2026 figure marks the highest quarterly Payables in data going back to Q4 2014.
- Compared with a year earlier, Payables was higher in four of the last six quarters, with growth averaging 191.2%.
- The best year-over-year quarter for Payables over five years was Q1 2026 (growth of 772.3%); the worst was Q3 2024 (a decline of 95.6%).
- Per Business Quant data, VKTX's Payables in the three quarters before Q2 2026 was $67.18 million (Q1 2026), $53.25 million (Q4 2025) and $4.41 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Viking Therapeutics | 3.10 Bn | 576.60 Mn | - | 69.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.01 Mn |
| Mar 31, 2026 | 67.18 Mn |
| Dec 31, 2025 | 53.25 Mn |
| Sep 30, 2025 | 4.41 Mn |
| Jun 30, 2025 | 5.49 Mn |
| Mar 31, 2025 | 7.70 Mn |
| Dec 31, 2024 | 9.81 Mn |
| Sep 30, 2024 | 254,000.00 |
| Jun 30, 2024 | 11.09 Mn |
| Mar 31, 2024 | 5.23 Mn |
| Dec 31, 2023 | 7.51 Mn |
| Sep 30, 2023 | 5.71 Mn |
| Jun 30, 2023 | 5.61 Mn |
| Mar 31, 2023 | 3.80 Mn |
| Dec 31, 2022 | 8.53 Mn |
| Sep 30, 2022 | 3.14 Mn |
| Jun 30, 2022 | 6.10 Mn |
| Mar 31, 2022 | 3.12 Mn |
| Dec 31, 2021 | 1.44 Mn |
| Sep 30, 2021 | 2.85 Mn |
API Access
Viking Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();